B
Belinda M Dcosta
Researcher at New York University
Publications - 21
Citations - 729
Belinda M Dcosta is an academic researcher from New York University. The author has contributed to research in topics: Antibody & Monoclonal antibody. The author has an hindex of 9, co-authored 12 publications receiving 261 citations.
Papers
More filters
Posted ContentDOI
Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies in Individuals With and Without Previous History of Infection
Takuya Tada,Hao Zhou,Belinda M Dcosta,Marie I. Samanovic,Amber Cornelius,Ramin S. Herati,Mark J. Mulligan,Nathaniel R. Landau +7 more
TL;DR: In this paper, the authors demonstrate that individuals can raise a broadly neutralizing humoral response by generating a polyclonal response to multiple spike protein epitopes that should protect against current and future SARS-CoV-2 infection.
Journal ArticleDOI
Prophylaxis and treatment of SARS-CoV-2 infection by an ACE2 receptor decoy in a preclinical animal model
TL;DR: In this article , a modified ACE2 ectodomain is fused to a single domain of an immunoglobulin heavy chain Fc region to suppress SARS-CoV-2 infection.
Posted ContentDOI
Prophylaxis and Treatment of SARS-CoV-2 infection by an ACE2 Receptor Decoy
TL;DR: In this paper , a modified ACE2 ectodomain is fused to a single domain of an immunoglobulin heavy chain Fc region to suppress SARS-CoV-2 infection.
Posted ContentDOI
Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 Infection
TL;DR: In this paper , the ACE2 decoy receptor was used to establish long-term prophylaxis against SARS-CoV-2 by adeno-associated and lentiviral vectors.
Journal ArticleDOI
Single-epitope T cell–based vaccine protects against SARS-CoV-2 infection in a preclinical animal model
TL;DR: In this article , the role of vaccine-elicited T cell responses in protection of CoV-2 spike proteins was investigated. But, the relative roles of antibodies and T cells in protection are not well understood.